|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.21 USD | -1.70% |
|
+2.97% | -5.42% |
| 21/01 | When America Starts to Feel Like a Risky Asset |  |
| 20/01 | Canaccord Genuity Upgrades BioMarin Pharmaceutical to Buy From Hold, Adjusts Price Target to $98 From $84 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.08TCr | |||||
| 7.73TCr | |||||
| 5.95TCr | |||||
| 5.75TCr | |||||
| 5.69TCr | |||||
| 2.52TCr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition